Collaborative Decisions for Higher Outcomes


This program was made attainable with assist from Novartis Prescribed drugs.

Video content material above is prompted by the next questions:

  • What are among the most necessary issues when beginning therapy for a newly identified affected person with CML? How do age, comorbidities, and different issues issue into the therapy plan?
    • Describe your finest practices in serving to newly identified sufferers with CML higher perceive their therapy plan given the complexities concerned.
  • In your expertise, what methods promote clear communication round therapy issues?
    • How can sufferers really feel empowered to collaborate with their healthcare staff to make an knowledgeable determination on the optimum preliminary therapy?

Hot Topics

Related Articles